![Cheng Ping Cai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cheng Ping Cai
Chief Executive Officer at Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Cheng Ping Cai active positions
Companies | Position | Start | End |
---|---|---|---|
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
![]() Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Director/Board Member | - | - |
Chief Executive Officer | - | - |
Career history of Cheng Ping Cai
Statistics
International
China | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
![]() Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Process Industries |
- Stock Market
- Insiders
- Cheng Ping Cai
- Experience